lesion Search Results


93
UGO Basile S.R.L electrolytic lesions
Electrolytic Lesions, supplied by UGO Basile S.R.L, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lesion/pmc07046334-521-5-12?v=UGO+Basile+S.R.L
Average 93 stars, based on 1 article reviews
electrolytic lesions - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology anti 8 oxo guanine
Anti 8 Oxo Guanine, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lesion/pm38278820-300-29-34?v=Santa+Cruz+Biotechnology
Average 94 stars, based on 1 article reviews
anti 8 oxo guanine - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

90
Hamamatsu cortical freeze-lesion
Cortical Freeze Lesion, supplied by Hamamatsu, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lesion/10__1016_slash_j__neures__2006__04__004-403-44-38?v=Hamamatsu
Average 90 stars, based on 1 article reviews
cortical freeze-lesion - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
NuOrtho Surgical Inc a non-ablation radiofrequency device designed for cartilage lesion stabilization
A Non Ablation Radiofrequency Device Designed For Cartilage Lesion Stabilization, supplied by NuOrtho Surgical Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lesion/us10016230-489-6-15?v=NuOrtho+Surgical+Inc
Average 90 stars, based on 1 article reviews
a non-ablation radiofrequency device designed for cartilage lesion stabilization - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Siemens AG synthetic lesion insertion tool
Synthetic Lesion Insertion Tool, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lesion/pm37962707-82-9-14?v=Siemens+AG
Average 90 stars, based on 1 article reviews
synthetic lesion insertion tool - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Biospring synthetic oligonucleotide 5′-tgagcacc[thf]agtccgccc-3′ containing the thf ap lesion
Transfection-based reporter assay for direct detection of transcriptional mutagenesis (TM) and mutagenic translesion DNA synthesis (TLS) templated by synthetic DNA lesions incorporated into vector DNA: ( a ) Scheme of the enhanced green fluorescent protein (EGFP) Q205* vector and of the derived constructs containing synthetic apurinic/apyrimidinic (AP) lesions (X) at the specified positions; ( b ) Detection of TM by flow cytometry of HeLa cells analyzed 24 h after transfection with constructs containing dA, <t>THF</t> and S-THF in double stranded DNA at the nucleotide 613 in TS. Scatter plots were gated by the DsRed fluorescence to generate the EGFP fluorescence distribution plots and calculate the median FL1-H. Grouped plots on the left show data of a representative experiment. Bar chart of the right shows quantification of the EGFP expression gain for n = 3 independent experiments (mean±SD); ( c ) Detection of mutagenic TLS. Cells transfected with constructs containing dT or THF at the nucleotide 613 <t>in</t> <t>NTS</t> opposite to a 18-nt gap were analyzed by flow cytometry 24 h post transfection. Mutant frequency was calculated as a ratio of EGFP-positive cells (in the upper right quadrant, UR) to total transfected cell count (UR+UL) for n = 3 independent experiments (mean ± SD).
Synthetic Oligonucleotide 5′ Tgagcacc[Thf]Agtccgccc 3′ Containing The Thf Ap Lesion, supplied by Biospring, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lesion/pmc07357151-89-15-18?v=Biospring
Average 90 stars, based on 1 article reviews
synthetic oligonucleotide 5′-tgagcacc[thf]agtccgccc-3′ containing the thf ap lesion - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare atypical urothelial cells of uncertain significance- cannot exclude high grade urothelial lesion
Transfection-based reporter assay for direct detection of transcriptional mutagenesis (TM) and mutagenic translesion DNA synthesis (TLS) templated by synthetic DNA lesions incorporated into vector DNA: ( a ) Scheme of the enhanced green fluorescent protein (EGFP) Q205* vector and of the derived constructs containing synthetic apurinic/apyrimidinic (AP) lesions (X) at the specified positions; ( b ) Detection of TM by flow cytometry of HeLa cells analyzed 24 h after transfection with constructs containing dA, <t>THF</t> and S-THF in double stranded DNA at the nucleotide 613 in TS. Scatter plots were gated by the DsRed fluorescence to generate the EGFP fluorescence distribution plots and calculate the median FL1-H. Grouped plots on the left show data of a representative experiment. Bar chart of the right shows quantification of the EGFP expression gain for n = 3 independent experiments (mean±SD); ( c ) Detection of mutagenic TLS. Cells transfected with constructs containing dT or THF at the nucleotide 613 <t>in</t> <t>NTS</t> opposite to a 18-nt gap were analyzed by flow cytometry 24 h post transfection. Mutant frequency was calculated as a ratio of EGFP-positive cells (in the upper right quadrant, UR) to total transfected cell count (UR+UL) for n = 3 independent experiments (mean ± SD).
Atypical Urothelial Cells Of Uncertain Significance Cannot Exclude High Grade Urothelial Lesion, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lesion/10__1038_slash_modpathol__2015__11-1786-3-20?v=Johns+Hopkins+HealthCare
Average 90 stars, based on 1 article reviews
atypical urothelial cells of uncertain significance- cannot exclude high grade urothelial lesion - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
MEDRA INC skin lesion
Transfection-based reporter assay for direct detection of transcriptional mutagenesis (TM) and mutagenic translesion DNA synthesis (TLS) templated by synthetic DNA lesions incorporated into vector DNA: ( a ) Scheme of the enhanced green fluorescent protein (EGFP) Q205* vector and of the derived constructs containing synthetic apurinic/apyrimidinic (AP) lesions (X) at the specified positions; ( b ) Detection of TM by flow cytometry of HeLa cells analyzed 24 h after transfection with constructs containing dA, <t>THF</t> and S-THF in double stranded DNA at the nucleotide 613 in TS. Scatter plots were gated by the DsRed fluorescence to generate the EGFP fluorescence distribution plots and calculate the median FL1-H. Grouped plots on the left show data of a representative experiment. Bar chart of the right shows quantification of the EGFP expression gain for n = 3 independent experiments (mean±SD); ( c ) Detection of mutagenic TLS. Cells transfected with constructs containing dT or THF at the nucleotide 613 <t>in</t> <t>NTS</t> opposite to a 18-nt gap were analyzed by flow cytometry 24 h post transfection. Mutant frequency was calculated as a ratio of EGFP-positive cells (in the upper right quadrant, UR) to total transfected cell count (UR+UL) for n = 3 independent experiments (mean ± SD).
Skin Lesion, supplied by MEDRA INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lesion/10__1186_slash_1476___511x___10___146-95-87-122?v=MEDRA+INC
Average 90 stars, based on 1 article reviews
skin lesion - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
CEM Corporation reference lesion not visible on
Transfection-based reporter assay for direct detection of transcriptional mutagenesis (TM) and mutagenic translesion DNA synthesis (TLS) templated by synthetic DNA lesions incorporated into vector DNA: ( a ) Scheme of the enhanced green fluorescent protein (EGFP) Q205* vector and of the derived constructs containing synthetic apurinic/apyrimidinic (AP) lesions (X) at the specified positions; ( b ) Detection of TM by flow cytometry of HeLa cells analyzed 24 h after transfection with constructs containing dA, <t>THF</t> and S-THF in double stranded DNA at the nucleotide 613 in TS. Scatter plots were gated by the DsRed fluorescence to generate the EGFP fluorescence distribution plots and calculate the median FL1-H. Grouped plots on the left show data of a representative experiment. Bar chart of the right shows quantification of the EGFP expression gain for n = 3 independent experiments (mean±SD); ( c ) Detection of mutagenic TLS. Cells transfected with constructs containing dT or THF at the nucleotide 613 <t>in</t> <t>NTS</t> opposite to a 18-nt gap were analyzed by flow cytometry 24 h post transfection. Mutant frequency was calculated as a ratio of EGFP-positive cells (in the upper right quadrant, UR) to total transfected cell count (UR+UL) for n = 3 independent experiments (mean ± SD).
Reference Lesion Not Visible On, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lesion/pmc10078876-187-2-7?v=CEM+Corporation
Average 90 stars, based on 1 article reviews
reference lesion not visible on - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Rocha labs soft, nodular, asymptomatic, slow-growing, sessile lesion on the right soft palate
Transfection-based reporter assay for direct detection of transcriptional mutagenesis (TM) and mutagenic translesion DNA synthesis (TLS) templated by synthetic DNA lesions incorporated into vector DNA: ( a ) Scheme of the enhanced green fluorescent protein (EGFP) Q205* vector and of the derived constructs containing synthetic apurinic/apyrimidinic (AP) lesions (X) at the specified positions; ( b ) Detection of TM by flow cytometry of HeLa cells analyzed 24 h after transfection with constructs containing dA, <t>THF</t> and S-THF in double stranded DNA at the nucleotide 613 in TS. Scatter plots were gated by the DsRed fluorescence to generate the EGFP fluorescence distribution plots and calculate the median FL1-H. Grouped plots on the left show data of a representative experiment. Bar chart of the right shows quantification of the EGFP expression gain for n = 3 independent experiments (mean±SD); ( c ) Detection of mutagenic TLS. Cells transfected with constructs containing dT or THF at the nucleotide 613 <t>in</t> <t>NTS</t> opposite to a 18-nt gap were analyzed by flow cytometry 24 h post transfection. Mutant frequency was calculated as a ratio of EGFP-positive cells (in the upper right quadrant, UR) to total transfected cell count (UR+UL) for n = 3 independent experiments (mean ± SD).
Soft, Nodular, Asymptomatic, Slow Growing, Sessile Lesion On The Right Soft Palate, supplied by Rocha labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lesion/pmc11213410-7-22-5?v=Rocha+labs
Average 90 stars, based on 1 article reviews
soft, nodular, asymptomatic, slow-growing, sessile lesion on the right soft palate - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
TransOral Pharmaceuticals egd removal tumor polyp/other lesion snare tech
Transfection-based reporter assay for direct detection of transcriptional mutagenesis (TM) and mutagenic translesion DNA synthesis (TLS) templated by synthetic DNA lesions incorporated into vector DNA: ( a ) Scheme of the enhanced green fluorescent protein (EGFP) Q205* vector and of the derived constructs containing synthetic apurinic/apyrimidinic (AP) lesions (X) at the specified positions; ( b ) Detection of TM by flow cytometry of HeLa cells analyzed 24 h after transfection with constructs containing dA, <t>THF</t> and S-THF in double stranded DNA at the nucleotide 613 in TS. Scatter plots were gated by the DsRed fluorescence to generate the EGFP fluorescence distribution plots and calculate the median FL1-H. Grouped plots on the left show data of a representative experiment. Bar chart of the right shows quantification of the EGFP expression gain for n = 3 independent experiments (mean±SD); ( c ) Detection of mutagenic TLS. Cells transfected with constructs containing dT or THF at the nucleotide 613 <t>in</t> <t>NTS</t> opposite to a 18-nt gap were analyzed by flow cytometry 24 h post transfection. Mutant frequency was calculated as a ratio of EGFP-positive cells (in the upper right quadrant, UR) to total transfected cell count (UR+UL) for n = 3 independent experiments (mean ± SD).
Egd Removal Tumor Polyp/Other Lesion Snare Tech, supplied by TransOral Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lesion/pm34979119-183-380-389?v=TransOral+Pharmaceuticals
Average 90 stars, based on 1 article reviews
egd removal tumor polyp/other lesion snare tech - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
LED Dental Inc visually enhanced lesion scope velscope
Transfection-based reporter assay for direct detection of transcriptional mutagenesis (TM) and mutagenic translesion DNA synthesis (TLS) templated by synthetic DNA lesions incorporated into vector DNA: ( a ) Scheme of the enhanced green fluorescent protein (EGFP) Q205* vector and of the derived constructs containing synthetic apurinic/apyrimidinic (AP) lesions (X) at the specified positions; ( b ) Detection of TM by flow cytometry of HeLa cells analyzed 24 h after transfection with constructs containing dA, <t>THF</t> and S-THF in double stranded DNA at the nucleotide 613 in TS. Scatter plots were gated by the DsRed fluorescence to generate the EGFP fluorescence distribution plots and calculate the median FL1-H. Grouped plots on the left show data of a representative experiment. Bar chart of the right shows quantification of the EGFP expression gain for n = 3 independent experiments (mean±SD); ( c ) Detection of mutagenic TLS. Cells transfected with constructs containing dT or THF at the nucleotide 613 <t>in</t> <t>NTS</t> opposite to a 18-nt gap were analyzed by flow cytometry 24 h post transfection. Mutant frequency was calculated as a ratio of EGFP-positive cells (in the upper right quadrant, UR) to total transfected cell count (UR+UL) for n = 3 independent experiments (mean ± SD).
Visually Enhanced Lesion Scope Velscope, supplied by LED Dental Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lesion/pm30412564-123-3-6?v=LED+Dental+Inc
Average 90 stars, based on 1 article reviews
visually enhanced lesion scope velscope - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Transfection-based reporter assay for direct detection of transcriptional mutagenesis (TM) and mutagenic translesion DNA synthesis (TLS) templated by synthetic DNA lesions incorporated into vector DNA: ( a ) Scheme of the enhanced green fluorescent protein (EGFP) Q205* vector and of the derived constructs containing synthetic apurinic/apyrimidinic (AP) lesions (X) at the specified positions; ( b ) Detection of TM by flow cytometry of HeLa cells analyzed 24 h after transfection with constructs containing dA, THF and S-THF in double stranded DNA at the nucleotide 613 in TS. Scatter plots were gated by the DsRed fluorescence to generate the EGFP fluorescence distribution plots and calculate the median FL1-H. Grouped plots on the left show data of a representative experiment. Bar chart of the right shows quantification of the EGFP expression gain for n = 3 independent experiments (mean±SD); ( c ) Detection of mutagenic TLS. Cells transfected with constructs containing dT or THF at the nucleotide 613 in NTS opposite to a 18-nt gap were analyzed by flow cytometry 24 h post transfection. Mutant frequency was calculated as a ratio of EGFP-positive cells (in the upper right quadrant, UR) to total transfected cell count (UR+UL) for n = 3 independent experiments (mean ± SD).

Journal: Biomolecules

Article Title: EGFP Reporters for Direct and Sensitive Detection of Mutagenic Bypass of DNA Lesions

doi: 10.3390/biom10060902

Figure Lengend Snippet: Transfection-based reporter assay for direct detection of transcriptional mutagenesis (TM) and mutagenic translesion DNA synthesis (TLS) templated by synthetic DNA lesions incorporated into vector DNA: ( a ) Scheme of the enhanced green fluorescent protein (EGFP) Q205* vector and of the derived constructs containing synthetic apurinic/apyrimidinic (AP) lesions (X) at the specified positions; ( b ) Detection of TM by flow cytometry of HeLa cells analyzed 24 h after transfection with constructs containing dA, THF and S-THF in double stranded DNA at the nucleotide 613 in TS. Scatter plots were gated by the DsRed fluorescence to generate the EGFP fluorescence distribution plots and calculate the median FL1-H. Grouped plots on the left show data of a representative experiment. Bar chart of the right shows quantification of the EGFP expression gain for n = 3 independent experiments (mean±SD); ( c ) Detection of mutagenic TLS. Cells transfected with constructs containing dT or THF at the nucleotide 613 in NTS opposite to a 18-nt gap were analyzed by flow cytometry 24 h post transfection. Mutant frequency was calculated as a ratio of EGFP-positive cells (in the upper right quadrant, UR) to total transfected cell count (UR+UL) for n = 3 independent experiments (mean ± SD).

Article Snippet: The resulting gap in the NTS was used to accommodate synthetic oligonucleotide 5′-TGAGCACC[THF]AGTCCGCCC-3′ containing the THF AP lesion (BioSpring GmbH) or the respective 5′-TGAGCACCTAGTCCGCCC-3′ unmodified oligonucleotide (Eurofins Genomics).

Techniques: Transfection, Reporter Assay, Mutagenesis, DNA Synthesis, Plasmid Preparation, Derivative Assay, Construct, Flow Cytometry, Fluorescence, Expressing, Cell Counting

Detection of TM by AP lesion in the EGFP A207P (c.619G>C) reporter: ( a ) Scheme of the EGFP A207P reporter indicating position of the lesion (X) at the nucleotide 619 of the TS and possible outcomes of the transcriptional bypass; ( b ) Verification of incorporation of the lesions into the vector DNA. Upper gel: proof of incorporation of synthetic DNA strands containing dG or the indicated AP lesions (THF, S-THF) into the TS. The vector containing the single-stranded 18-nt gap in the TS migrates as open circular form (oc). Efficient ligation of synthetic oligonucleotides into the gap is confirmed by reconstitution of the covalently closed circular form (cc). Lower gel: verification of incision of the THF lesion by human APE1 and inhibited incision of the S-THF; ( c ) TM visualized by fluorescence microscopy and quantitative flow cytometry as a reversal of the non-fluorescent EGFP phenotype. HeLa cells were transfected with the indicated EGFP constructs in the presence of DsRed-Monomer as a transfection marker.

Journal: Biomolecules

Article Title: EGFP Reporters for Direct and Sensitive Detection of Mutagenic Bypass of DNA Lesions

doi: 10.3390/biom10060902

Figure Lengend Snippet: Detection of TM by AP lesion in the EGFP A207P (c.619G>C) reporter: ( a ) Scheme of the EGFP A207P reporter indicating position of the lesion (X) at the nucleotide 619 of the TS and possible outcomes of the transcriptional bypass; ( b ) Verification of incorporation of the lesions into the vector DNA. Upper gel: proof of incorporation of synthetic DNA strands containing dG or the indicated AP lesions (THF, S-THF) into the TS. The vector containing the single-stranded 18-nt gap in the TS migrates as open circular form (oc). Efficient ligation of synthetic oligonucleotides into the gap is confirmed by reconstitution of the covalently closed circular form (cc). Lower gel: verification of incision of the THF lesion by human APE1 and inhibited incision of the S-THF; ( c ) TM visualized by fluorescence microscopy and quantitative flow cytometry as a reversal of the non-fluorescent EGFP phenotype. HeLa cells were transfected with the indicated EGFP constructs in the presence of DsRed-Monomer as a transfection marker.

Article Snippet: The resulting gap in the NTS was used to accommodate synthetic oligonucleotide 5′-TGAGCACC[THF]AGTCCGCCC-3′ containing the THF AP lesion (BioSpring GmbH) or the respective 5′-TGAGCACCTAGTCCGCCC-3′ unmodified oligonucleotide (Eurofins Genomics).

Techniques: Plasmid Preparation, Ligation, Fluorescence, Microscopy, Flow Cytometry, Transfection, Construct, Marker

Detection of mutagenic TLS over the synthetic AP lesion in the EGFP A207P (c.619G>C) reporter by reversion to the fluorescent phenotype: ( a ) verification of the presence of gaps in the TS opposite to the specified nucleotides in the TLS reporter constructs by inhibited ligation and its reconstitution with matching synthetic 18-mer oligonucleotides. THF lesion at the nucleotide 619 is marked with “X”; ( b ) Repair of the 18-nt gap by re-synthesis of the missing TS fragment in the construct encoding the functional EGFP (c.619G) and detection of mutagenic TLS on the EGFP A207P template containing no modification (c.619C) or AP lesion (c.619THF) at the nucleotide 619. HeLa cells were transfected with the indicated constructs together with the DsRed-Monomer expression vector as a transfection marker. The fractions of EGFP-positive cells (UR/(UR+UL)×100%) were used as an estimate of the repair and mutation rates, as in ( n = 2 independent experiments, mean ± range).

Journal: Biomolecules

Article Title: EGFP Reporters for Direct and Sensitive Detection of Mutagenic Bypass of DNA Lesions

doi: 10.3390/biom10060902

Figure Lengend Snippet: Detection of mutagenic TLS over the synthetic AP lesion in the EGFP A207P (c.619G>C) reporter by reversion to the fluorescent phenotype: ( a ) verification of the presence of gaps in the TS opposite to the specified nucleotides in the TLS reporter constructs by inhibited ligation and its reconstitution with matching synthetic 18-mer oligonucleotides. THF lesion at the nucleotide 619 is marked with “X”; ( b ) Repair of the 18-nt gap by re-synthesis of the missing TS fragment in the construct encoding the functional EGFP (c.619G) and detection of mutagenic TLS on the EGFP A207P template containing no modification (c.619C) or AP lesion (c.619THF) at the nucleotide 619. HeLa cells were transfected with the indicated constructs together with the DsRed-Monomer expression vector as a transfection marker. The fractions of EGFP-positive cells (UR/(UR+UL)×100%) were used as an estimate of the repair and mutation rates, as in ( n = 2 independent experiments, mean ± range).

Article Snippet: The resulting gap in the NTS was used to accommodate synthetic oligonucleotide 5′-TGAGCACC[THF]AGTCCGCCC-3′ containing the THF AP lesion (BioSpring GmbH) or the respective 5′-TGAGCACCTAGTCCGCCC-3′ unmodified oligonucleotide (Eurofins Genomics).

Techniques: Construct, Ligation, Functional Assay, Modification, Transfection, Expressing, Plasmid Preparation, Marker, Mutagenesis